Targeting Cholesterol Metabolism as Efficient Antiviral Strategy Against the Hepatitis E Virus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1016/j.jcmgh.2021.02.002
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2021
- Urheber
-
Glitscher, Mirco
Martín, David Heiler
Woytinek, Kathrin
Schmidt, Benjamin
Tabari, Denna
Scholl, Catharina
Stingl, Julia C.
Seelow, Evelyn
Choi, Mira
Hildt, Eberhard
- DOI
-
10.18154/RWTH-CONV-247669
- URN
-
urn:nbn:de:101:1-2023020300550551292081
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Glitscher, Mirco
- Martín, David Heiler
- Woytinek, Kathrin
- Schmidt, Benjamin
- Tabari, Denna
- Scholl, Catharina
- Stingl, Julia C.
- Seelow, Evelyn
- Choi, Mira
- Hildt, Eberhard
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2021
Ähnliche Objekte (12)
Dietary proteins, cholesterol metabolism, and atherosclerosis
Targeting cholesterol crystals in atherosclerosis with cholesterol solubilizing 2-hydroxypropyl-beta-cyclodextrin
Targeting V-ATPase influences cancer cell cholesterol metabolism and biophysical properties - a new option for HCC therapy
Cholesterol metabolism in mouse models of Multiple Sclerosis
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Hepatitis C virus: from molecular virology to antiviral therapy
Eimeria bovis-mediated modulation of the host cell cholesterol metabolism
Eimeria bovis-mediated modulation of the host cell cholesterol metabolism
Eimeria bovis infection modulates endothelial host cell cholesterol metabolism for successful replication
The ERLIN complex regulates cholesterol metabolism and mediates the RNF170-TMUB1 interaction
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Influence of the hepatitis C genotype on the antiviral immune response
Dietary proteins, cholesterol metabolism, and atherosclerosis
Targeting cholesterol crystals in atherosclerosis with cholesterol solubilizing 2-hydroxypropyl-beta-cyclodextrin
Targeting V-ATPase influences cancer cell cholesterol metabolism and biophysical properties - a new option for HCC therapy
Cholesterol metabolism in mouse models of Multiple Sclerosis
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Hepatitis C virus: from molecular virology to antiviral therapy
Eimeria bovis-mediated modulation of the host cell cholesterol metabolism
Eimeria bovis-mediated modulation of the host cell cholesterol metabolism
Eimeria bovis infection modulates endothelial host cell cholesterol metabolism for successful replication
The ERLIN complex regulates cholesterol metabolism and mediates the RNF170-TMUB1 interaction
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
Influence of the hepatitis C genotype on the antiviral immune response
Dietary proteins, cholesterol metabolism, and atherosclerosis
Targeting cholesterol crystals in atherosclerosis with cholesterol solubilizing 2-hydroxypropyl-beta-cyclodextrin
Targeting V-ATPase influences cancer cell cholesterol metabolism and biophysical properties - a new option for HCC therapy
Cholesterol metabolism in mouse models of Multiple Sclerosis
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Hepatitis C virus: from molecular virology to antiviral therapy
Eimeria bovis-mediated modulation of the host cell cholesterol metabolism
Eimeria bovis-mediated modulation of the host cell cholesterol metabolism
Eimeria bovis infection modulates endothelial host cell cholesterol metabolism for successful replication
The ERLIN complex regulates cholesterol metabolism and mediates the RNF170-TMUB1 interaction
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?